By: IPP Bureau
Last updated : September 29, 2025 10:09 am
Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
Aptar Pharma announced the opening of its new expanded R&D Center in Le Vaudreuil and Val-de-Reuil, France, which increases research and development capabilities across Aptar Pharma’s proprietary drug delivery business.
This new R&D Center is on the site of Aptar’s Le Vaudreuil and Val-de-Reuil manufacturing sites in France, and one of AptarGroup’s 11 global innovation centers. This expansion reflects Aptar’s commitment to innovation and strategic focus on research and development. Today, over 10% of Aptar Pharma’s global workforce is dedicated to R&D, supported by a robust portfolio of nearly 4,700 active and pending patents worldwide.
Fully operational since July 2025, Aptar Pharma’s new 3,000-square-meter (32,000-square-foot) R&D Center houses 170 employees dedicated to advancing pharmaceutical innovation. Designed to foster adaptability and collaboration, the two-story facility features open, sky-lit spaces and integrates cutting-edge technologies – including digital simulation, rapid prototyping, predictive modelling, data utilization and artificial intelligence. These capabilities accelerate and de-risk the development and market launch of next-generation drug delivery solutions.
The Center is equipped with rooftop solar panels, a heat recovery unit, a rainwater harvesting system as well as other features in line with Aptar’s sustainable building guidelines. The installation of solar panels will provide up to 30% of the anticipated total electricity consumption of the building.
“Innovation is at the heart of everything we do,” said Alex Theodorakis, President of Aptar Pharma Prescription. “Our strong emphasis on research and development drives the creation of affordable, sustainable and forward-thinking drug delivery solutions and connected devices. At the same time, we’re continuously evolving existing products to meet emerging market needs and customer expectations. This new state-of-the-art R&D Center empowers us to accelerate meaningful innovation and deliver differentiated value to the pharmaceutical industry.”
Aptar operates 11 Innovation Centers worldwide, including this expanded R&D center in Le Vaudreuil / Val de Reuil, France.